The complete evolution of oral semaglutide — from Rybelsus off-label prescribing to the FDA-approved Wegovy pill. Dosing differences, indications, and what it means for patients in 2026.
Oral amycretin, danuglipron (discontinued), elecoglipron, and more — the next generation of oral obesity drugs in clinical trials and what the data shows so far.
Oral GLP-1 medications aren't for everyone. A clinical perspective on when oral makes sense, when injectable is better, and how to decide with your provider.
A transparent, up-to-date pricing guide for every oral GLP-1 medication available in May 2026 — Foundayo, Wegovy pill, and Rybelsus, with real costs at every dose level.
Oral GLP-1 medications like Foundayo and the Wegovy pill avoid needles but still carry real side effects. Here's what clinical trials show about GI effects, how they compare to injectables…
Wegovy pill and Foundayo are both oral GLP-1 weight loss medications, but they work differently and have different requirements. A head-to-head comparison of dosing, effectiveness…
Foundayo (orforglipron) received FDA approval April 1, 2026 — the first oral GLP-1 you can take any time, with or without food. Complete guide to dosing, pricing, trial data, and access.
BMI thresholds, comorbidity requirements, insurance criteria — here's who can actually get prescribed oral semaglutide and through which channels.
Both are oral semaglutide. One is approved for weight loss, one is not. The doses are different. The cost is different. Here's what matters.
Eli Lilly's oral tirzepatide is in late-stage clinical trials. Here's the current status, expected timeline, and how it might compare to oral semaglutide.
Practical guidance for switching from injectable Wegovy, Ozempic, or Zepbound to the Wegovy pill or Foundayo — timing, dose mapping, side effects, and what to discuss with your doctor.
The Wegovy pill is here. We compare the 25mg oral dose to the 2.4mg weekly injection on weight loss, side effects, cost, and daily logistics.
Weight regain after discontinuing GLP-1 medication is well-documented. Here's what the data shows, why it happens, and strategies for managing the transition.
GI side effects are the main reason people quit GLP-1 medications. Here's the realistic timeline — and what actually helps.
Weight loss plateaus on GLP-1 medications are normal and expected. Here's the physiology behind them, when to worry, and evidence-based strategies for breaking through.
From the Wegovy pill at $149/month to savings programs and compounded alternatives — here's what oral GLP-1 treatment actually costs in 2026.
Oral semaglutide slows gastric emptying, which changes how your body handles food and other medications. Here's the practical guide.
Only about 1% of an oral semaglutide dose actually reaches your bloodstream. Here's why that's not as bad as it sounds, and why dosing conditions matter so much.
GLP-1 medications reduce appetite — which can reduce fuel. Here's how to exercise effectively without undereating, and why strength training matters more than cardio.
Rybelsus was the first oral GLP-1 for diabetes. Here's where it fits in the treatment cascade, how it compares to metformin, and when your doctor might add it.
Oral semaglutide has specific dosing requirements that directly affect how much medication your body absorbs. Here's the protocol, why it matters, and what happens when you skip steps.
Which oral GLP-1 pills are covered by insurance in 2026? Wegovy pill, Foundayo, and Rybelsus coverage by plan type — commercial, Medicare, Medicaid, and self-pay options.
Not all weight loss pills are GLP-1s. Here's how the Wegovy pill stacks up against older oral options — and when those alternatives might still make sense.
Real 5-year cost math for every oral GLP-1 option in 2026. Wegovy pill, Rybelsus, Foundayo, compounded semaglutide. With insurance. Without insurance. What the total actually adds up to.
The complete reference: every FDA warning letter issued to telehealth compounded GLP-1 companies in 2026. Dates, letter numbers, violations, and what each means for consumers.
Foundayo (orforglipron) has no fasting requirements — take it any time, with or without food. Here's why that's a bigger deal than it sounds, and how it compares to the Wegovy pill.
Eli Lilly holds the patents on tirzepatide. They had every reason to make an oral version. Instead they invented a different molecule entirely. Here's why that matters for anyone buying…
Rybelsus bioavailability is 0.4-1%. The science of why most of your oral semaglutide pill never works, why the fasting protocol exists, and what this means for compounded alternatives.
A clear pharmacology explainer for non-specialists: what GLP-1 is, how the medications mimic it, and why it took so long to make an oral version that works.
A complete guide to Foundayo (orforglipron): how the first small-molecule oral GLP-1 works, ATTAIN-1 trial results, dosing, pricing via LillyDirect, and how it compares to Wegovy pill.
An honest review of Wellorithm's $147/month compounded semaglutide program. Pricing, billing terms, clinical model, and how it compares to our recommended alternatives.
A detailed review of Sprout Health's orally disintegrating tablet (ODT) compounded GLP-1 program. Pricing, clinical model, regulatory standing, and how it compares to alternatives.
A detailed review of Strut Health's compounded GLP-1 program after the February 2026 FDA warning letter. What the letter said, what Strut has done since, and alternatives worth considering.
A combined review of SkinnyRx and 24hrDoc after both received February 2026 FDA warning letters. What the violations were, what changed, and which alternatives we recommend instead.
A transparent review of MEDVi's compounded GLP-1 program — including the February 2026 FDA warning letter, the OpenLoop data breach, and what safer alternatives exist.
An honest evidence review of sublingual compounded semaglutide. Pharmacology, published studies, the marketing-vs-evidence gap, and how to evaluate providers.
A plain-English guide to oral GLP-1 insurance coverage in 2026. Rybelsus, Wegovy pill, Foundayo. Prior authorization, manufacturer savings cards, and how to appeal denials.
The cheapest oral GLP-1 options in 2026 compared honestly. FDA-approved and compounded pricing, insurance paths, hidden costs, and how to find real value.
A practical 90-day guide to starting an oral GLP-1. What to expect week by week, how to manage side effects, dose titration, and red flags that matter.
Honest Care Bare Rx review. $199/month bundled oral GLP-1 program with HSA/FSA acceptance and 50-state coverage. Pricing, program structure, and who it fits.
Honest MangoRx Slim review. Compounded semaglutide ODT from a publicly-traded company. Pricing, pharmacy partner, dosing flexibility, and how it compares to alternatives.
Honest SHED review. Four compounded oral formats plus brand Wegovy pill access. Pricing, accreditations, 10% weight-loss guarantee, and how SHED compares.
Sesame Care review for oral GLP-1. Novo Nordisk Recognized Care Provider. Get Wegovy pill at $149/month through FDA-approved medications only.
Oral semaglutide (Wegovy pill) vs injectable semaglutide (Wegovy) compared honestly. OASIS 4 vs STEP 1 trial data, cost, convenience, and which is right for you.
Every oral GLP-1 option in 2026 compared: FDA-approved Wegovy pill, Foundayo, Rybelsus, plus compounded alternatives. Efficacy, cost, and who should consider each.